Skip to main content

Table 2 Characterization of population according to acute pancreatitis mortality

From: Red cell distribution width and red cell distribution width to total serum calcium ratio as major predictors of severity and mortality in acute pancreatitis

Variable Nonsurvivors (n = 16) Survivors (n = 166) pU/pM aOR, 95%CI in M
Age (yo), μ ± σ 71.6 ± 14.3 65.8 ± 15.1 0.123/−
Male gender, n(%) 11(68.8%) 5(53.6%) 0.245/−
Alcoholism, n(%) 4(25.0%) 36(21.7%) 0.760/−
Smoking, n(%) 0(0.0%) 16(9.6%) 0.481/−
Hospital stay, median(IQR) 6.5(2–62) 11.0(2–83) 0.071/−
Comorbiditiesa, n(%) 15(93.7%) 143(86.1%) 0.391/−
Laboratory and gasometrical parameters
 WBC count (cells/mm3), μ ± σ 16,810.0 ± 13,490.0 1779.1 ± 1214.1 0.465/−
 AST (IU/L), μ ± σ 144.6 ± 132.4 271.6 ± 198.1 0.416/−
 ALT (IU/L), μ ± σ 123.2 ± 100.2 227.8 ± 175.4 0.116/−
 Total bilirubin (mg/dL), μ ± σ 1.8 ± 1.2 2.4 ± 2.3 0.869/−
 Platelet count (cells/mm3), μ ± σ 174.4 ± 67.0 214.0 ± 80.5 0.057/−
 BUN (mg/dL), μ ± σ 35.3 ± 20.1 21.9 ± 12.5 0.002/−
 Creatinine (mg/dL), μ ± σ 2.2 ± 1.4 1.1 ± 0.8 < 0.001/−
 INR, μ ± σ 1.5 ± 1.0 2.1 ± 1.2 0.018/−
 Albumin (g/dL), μ ± σ 3.5 ± 0.6 3.8 ± 0.7 0.074/−
 LDH (IU/L), μ ± σ 465.1 ± 287.8 453.9 ± 332.7 0.207/−
 Serum glucose (mg/dL), μ ± σ 164.1 ± 104.5 147.3 ± 53.2 0.945/−
 Hemoglobin (mg/dL), μ ± σ 13.7 ± 3.0 13.7 ± 2.0 0.889/−
 Hematocrit (%), μ ± σ 41.7 ± 7.5 40.7 ± 5.7 0.630/−
 Serum amylase (IU/L), μ ± σ 1565.1 ± 1273.3 1703.4 ± 1506.4 0.391/−
 CRP0h (mg/dL), μ ± σ 10.4 ± 9.6 5.9 ± 3.9 0.046/−
 CRP24h (mg/dL), μ ± σ 21.8 ± 10.4 15.7 ± 10.3 0.028/−
 Lactate (mg/dL), μ ± σ 3.6 ± 1.8 2.0 ± 1.4 < 0.001/0.019 1.164, [1.003;1.474]
 D-dimers (μg/mL), μ ± σ 9.1 ± 6.8 5.9 ± 4.6 0.042/−
 Total serum calcium (mg/dL), μ ± σ 8.0 ± 1.1 8.9 ± 1.1 0.001/−
 RDW0h (%), μ ± σ 15.3 ± 1.4 13.5 ± 1.3 < 0.001/< 0.001 1.038, [1.011;1.087]
 RDW24h (%), μ ± σ 15.1 ± 1.4 13.4 ± 1.6 < 0.001/0.005 1.006, [1.001;1.040]
 RDW0h-to-total serum calcium ratio, μ ± σ 2.0 ± 0.3 1.6 ± 0.3 < 0.001/< 0.001 1.018, [1.007;1.135]
 RDW0h-to-platelets ratio, μ ± σ 0.10 ± 0.04 0.07 ± 0.03 0.015/−  
Prognostic scores
 Ranson score, μ ± σ 2.7 ± 1.2 2.0 ± 1.2 0.023/< 0.001 1.019, [1.005;1.170]
 BISAP score, μ ± σ 2.0 ± 1.0 1.3 ± 0.8 0.003/< 0.001 1.010, [1.003;1.059]
 Modified Marshall score, μ ± σ 1.2 ± 1.0 0.6 ± 0.3 < 0.001/0.020 1.109, [1.049;1.169]
  1. ALT alanine aminotransferase, AST aspartate aminotransferase, aOR adjusted odds ratio, BUN blood urea nitrogen, CRP0h C-reactive protein at 0 h, CRP24h C-reactive protein at 24 h, CI confidence interval, INR international normalized ratio, IQR interquartile range, LDH lactate dehydrogenase, M multivariate analysis, RDW0h red cell distribution width at 0 h, RDW24h red cell distribution width at 24 h, U univariate analysis, WBC white blood cells
  2. a Only presented significant comorbidities in univariate analysis; Comorbidities evaluated: Neurological, cardiovascular, respiratory and gastrointestinal conditions, malignancy and immunosuppression